Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed for mood and anxiety disorders, the same conditions under which psychedelic-assisted therapies are gaining renewed interest. However, it remains unclear how SSRI treatment may influence sensitivity to psychedelics, particularly through the shared engagement of serotonergic pathways. Here, we used the head-twitch response...
Psychedelic MedicineDecember 19, 2025Amanda Husein, Madalynn Traylor, M. Frances Vest et al.
Background: Psilocybin has been granted breakthrough therapy status in the United States, speeding its advancement from research to clinical care. Due to the controversial nature of psilocybin, psychiatrists may not be fully prepared to incorporate it into clinical practice. The current study aimed to evaluate the opinions toward psilocybin among practicing psychiatrists in Louisiana. Louisiana...
Psychedelic MedicineAhead of Print Psychedelic Research as a Career Path: A Roundtable Discussion with Early Career Researchers in the FieldModerators: Jacob S. Aday, Natasha L. Mason, Participants: Bo Jarrett Wood, Hannah M. Kramer, Cynthia E. Ortiz, M. Frances Vest, Caroline Sagrera, and C. J. HealyModerators: Jacob S. Aday*Address correspondence to: Jacob S. Aday, PhD, Department of...